A carregar...
Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance
Tofacitinib is an oral, Janus kinase (JAK) molecule, which selectively inhibits Janus-associated tyrosine kinases JAK1 and JAK3. It has already shown efficacy in the treatment of rheumatoid arthritis and the prevention of organ allograft rejection in kidney transplantation. Two separate phase III pl...
Na minha lista:
| Publicado no: | Frontline Gastroenterol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7873536/ https://ncbi.nlm.nih.gov/pubmed/33613945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/flgastro-2020-101502 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|